Incidence, potential risk factors and clinical impacts of incomplete device endothelialization
Atrial fibrillation (AF) is known to cause a 4- to 5-fold increased risk of ischemic stroke. Oral anticoagulation with non-vitamin K oral anticoagulants (NOACs) or vitamin K antagonists are popularly recommended first-line treatment for reducing stroke risk, but bleeding complications and nonadherence are barriers to effective anticoagulation therapy. Device related thrombus (DRT)...
Atrial fibrillation (AF) is known to cause a 4- to 5-fold increased risk of ischemic stroke. Oral anticoagulation with non-vitamin K oral anticoagulants (NOACs) or vitamin K antagonists are popularly recommended first-line treatment for reducing stroke risk, but bleeding complications and nonadherence are barriers to effective anticoagulation therapy.
Device related thrombus (DRT) formation, one of the main concerns after LAAC, is generally reported to be 2–5% cases. Especially, it may develop on the poorly endothelialized device following intervention, and have a potential negative impact on the risk of stroke and thromboembolic events. Now, what poses as risk factors of incomplete device endothelialization?
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd